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ABSTRACT: Introduction: Over the past 10 years, the use of
zebrafish for scientific research in the area of muscle develop-
ment has increased dramatically. Although several protocols exist
for the isolation of adult myoblast progenitors from larger fish, no
standardized protocol exists for the isolation of myogenic progen-
itors from adult zebrafish muscle. Methods: Using a variant of a
mammalian myoblast isolation protocol, zebrafish muscle pro-
genitors have been isolated from the total dorsal myotome. These
zebrafish myoblast progenitors can be cultured for several pas-
sages and then differentiated into multinucleated, mature myo-
tubes. Results: Transcriptome analysis of these cells during
myogenic differentiation revealed a strong downregulation of plu-
ripotency genes, while, conversely, showing an upregulation of
myogenic signaling and structural genes. Conclusions: Together
these studies provide a simple, yet detailed method for the isola-
tion and culture of myogenic progenitors from adult zebrafish,
while further promoting their therapeutic potential for the study of
muscle disease and drug screening.
Muscle Nerve 43: 741–750, 2011
The use of zebrafish (Brachydanio rerio) as an ani-
mal model for scientific research has dramatically
increased in recent years as more researchers recog-
nize its value in elucidating molecular pathways in
normal and diseased states.1 The ability to knock
down gene expression in embryos using morpholi-
nos has allowed researchers to perform reverse
genetics to identify genes essential for vertebrate de-
velopment in a high-throughput fashion. In addi-
tion, the zebrafish is an excellent model to study
early myogenesis in an ex utero setting, which
allows for the molecular determination of the tim-
ing events in somatogenesis that occur from the ini-
tial somites to mature myofibers.2,3 Over the past
few years, several zebrafish skeletal muscle mutants
with links to human myopathies and dystrophies
have been identified, such as sapje and sapje-like (dys-
trophin), runzel (titin), softy (laminin b2), and candy-
floss (laminin a2), and have provided valuable
insight into the progression of muscle disease.4–8
The high degree of evolutionary conservation of
myogenesis between mammals and zebrafish ren-
ders loss-of-function (morpholinos) or gain-of-func-
tion (transgenic fish) experimentation both eco-
nomical and rapid.9 Consequently, the development
of an efficient and simple method for the isolation
and in vitro study of myogenic progenitors from
adult zebrafish muscle mutants, combined with the
amenability of zebrafish for high-throughput chemi-
cal screens, can significantly accelerate identifica-
tion of compounds and optimization of parameters
for new therapeutic approaches prior to further
evaluation in mammalian disease models.
There are many approaches for treating muscu-
lar dystrophies and myopathies. Cell-based therapy
is among the more promising options.10 For cell
therapy, therapeutic cells are transferred to the
host recipient to treat the cause or symptoms of
the disease. Recent experiments in mouse trans-
genic models have focused on enriching for cells
with myogenic potential in the hopes that these
cells will be able to successfully engraft and correct
the disease. The molecular pathways involved in
early zebrafish myogenesis have been shown to
share a large amount of evolutionary conservation
with that of the more well-characterized mouse ani-
mal model.11 Recent advances in zebrafish myo-
genesis have demonstrated that blastomeres iso-
lated from zebrafish embryos can be transduced
into myogenic cell cultures with the addition of
hedgehog.12 Further experiments in larger fish
species, such as the Atlantic salmon (Salmo salar)
and the rainbow trout (Oncorhynchus mykiss), have
resulted in the successful isolation, differentiation,
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and molecular characterization of adult dorsal
myotome myoblasts grown in cell culture.13,14
Despite the increased interest in the use of
zebrafish to study muscle development and dis-
ease, no current protocol exists for the successful
isolation and characterization of myogenic pro-
genitors from the adult zebrafish skeletal mus-
cle.15 Using a variant method from mammalian
myoblast progenitor cell isolation,16 we have suc-
cessfully isolated zebrafish myogenic progenitor
cells from adult zebrafish whole dorsal myotome
muscle. Utilizing an a-actin–red flourescent pro-
tein (RFP) transgenic fish line that expresses RFP
exclusively in skeletal muscle, these adult zebra-
fish myogenic progenitor cells have been
expanded and differentiated into multinucleated
myotubes. Microarray transcriptome data obtained
from these cells taken at critical time-points dur-
ing myogenic differentiation have revealed a clus-
tering of downregulated myogenic pluripotency
markers (pax7a, myf5, ncam1a, etc.), but strong
upregulation of myogenic signaling and structural
genes (desmin, caveolin-3, a-actin-1a, etc). To-
gether, these experiments provide a simple, yet
concise method for the isolation of adult zebra-
fish skeletal myoblast progenitors from whole
dorsal myotome muscle, which greatly expands
zebrafish utility for in vitro cell culture differentia-
tion experiments, myoblast transplantation, and
chemical screening for novel drug-based therapies
in muscle mutants.
METHODS
Fish Lines. The a-actin–RFP transgenic fish line
was a generous gift from H.J. Tsai (Taiwan National
University) and has been described previously.17
Additional experiments were done utilizing the
wild-type AB strain, which was obtained from the
Children’s Hospital aquatics program and main-
tained in their aquatics facility. All animal protocols
were approved by the animal resources committee
of Children’s Hospital.
Isolation of Zebrafish Myogenic Muscle Cells from
Whole Dorsal Myotome. For each cell preparation,
15–20 adult zebrafish were euthanized in tricaine
(Sigma-Aldrich) and the whole zebrafish was
placed in 100% ethanol for 30 seconds as the first
step for sterilization. The fish’s head, tail, and fins
were removed with a scalpel, and the skin and in-
ternal organs were removed with forceps. The
fish’s body was sterilized in 10% bleach for 30 sec-
onds and then washed twice in sterile phosphate-
buffered saline (PBS) for another 30 seconds. Fish
dorsal muscle and bone were minced with a scalpel
and then transferred to a pre-weighed culture
plate. For every gram of fish tissue, 3.5 ml of colla-
genase IV (10 mg/ml stock solution) and 3.5 ml of
dispase (2.4 units/ml stock solution; Worthington
Chemicals) were added and mixed by pipetting
(Worthington). The solution was incubated at
room temperature for 45 minutes (mixed every 10
minutes by pipette) before 10 ml of growth me-
dium (L15; Sigma-Aldrich), 3% fetal calf serum,
100 lg/ml penicillin/streptomycin, 2 mM gluta-
mine, and 0.8 mM CaCl2 (all Sigma-Aldrich) were
added to the cells to quench the activity of the col-
lagenase and dispase proteases. Debris was
removed by filtering the cells through a 70-lm
filter and then through two 40-lm filters (BD
Biosciences). On each occasion, the filters were
washed with 5 ml of L15 medium.
The cells were isolated by centrifugation at 1000
 g for 10 minutes at 9C, and the supernatant was
aspirated. The cells were then resuspended in 3 ml
of red blood cell lysis buffer (Qiagen) and incu-
bated for 3 minutes at room temperature before
neutralization with 22 ml of L15 growth medium.
The cells were then pelleted at 1000  g for 10
minutes at 9C, the supernatant aspirated, and the
cell pellet resuspended in 3 ml of cold 1 PBS and
layered on top of 4 ml of Ficoll-Paque gradient (GE
Healthcare) in a 15-ml tube. Samples were then cen-
trifuged at 1400  g for 40 minutes at 9C. A mono-
nuclear cell layer was then extracted by pipette and
washed with 10 ml of ice-cold 1 PBS. Afterwards,
the cells were resuspended in 10 ml of ice-cold L15
buffer. The cell density was determined using an
automated hemocytometer (Countess; Invitrogen),
and the cell suspension was diluted in L15 growth
medium.
The cells were then pre-plated on uncoated
plates for 1 hour in a 28C tissue culture incubator
at 5% CO2. After pre-plating, the cellular superna-
tant (non-adherent cells) was removed and placed
on laminin-coated plates (BD Biocoat). Alterna-
tively, 0.1% gelatin-coated (porcine) plates can be
used. The medium was changed every 3 days. The
zebrafish myogenic progenitor cells were able to
be grown for up to seven doublings before evi-
dence of cellular senescence, with an average of
four and five doublings per myoblast isolation. On
average, a yield of 5–10 million live (trypan blue–
negative) cells were isolated from each preparation
of between 15 and 20 adult zebrafish. Lower yields
of 100,000–500,000 live cells were isolated when
using 1–5 adult zebrafish.
An alternative to the L15 growth medium was
later used in zebrafish myogenic progenitor cell
cultures and achieved the same results. Human
skeletal myoblast growth medium (Promocell) that
contained 20% fetal bovine serum (Atlanta Biologi-
cals), 1 antibiotic–antimycotic (Invitrogen), and
1 Glutamax (Invitrogen), and supplemented with
3 ng/ml recombinant human fibroblast-like growth
742 Isolation and Transcriptome Analysis of Adult Zebrafish Myogenic Progenitor Cells MUSCLE & NERVE May 2011
factor (rhFGF; Promega), can be used in lieu of
the L15 growth medium.
Myogenic Differentiation of Adult Zebrafish Myogenic
Progenitor Cells. Approximately 300,000 cells/well
were plated into six-well 0.1% gelatin-coated plates
in 2 ml of growth medium and grown to 95% con-
fluence. The medium was then changed to differen-
tiation medium consisting of: 2% horse serum
(Gibco) in Dulbecco modified Eagle medium
(DMEM; Mediatech, Inc.) supplemented with 1
antibiotic–antimycotic (Invitrogen) and 1 Gluta-
max (Invitrogen). The differentiation medium was
changed every other day, and cells were monitored
for myotube fusion by phase and fluorescent micros-
copy. Multinucleated myotubes were observed
during days 4–7.
Immunohistochemistry. The following primary anti-
bodies were used for immunohistochemistry of zebra-
fish myogenic progenitor cells: Pax3 mouse monoclo-
nal (1:25; Developmental Studies Hybridoma Bank);
Pax7 mouse monoclonal (1:25; Developmental Stud-
ies Hybridoma Bank); anti-MyoD1 rabbit polyclonal
(1:50; Santa Cruz Biotechnology); and anti-myogenin
rabbit polyclonal (1:50; M-225; Santa Cruz Biotech-
nology). The myogenin antibody has been character-
ized previously in early zebrafish myogenic progeni-
tor cells.18 The zebrafish myod1 epitope has been
shown to be recognized by the myf5 antibody (Santa
Cruz Biotechnology).19
Approximately, 100,000 cells were pre-plated on
uncoated coverslides (Nunc, Lab-Tek) and, after a
1-hour pre-plating, the supernatant was plated onto
0.1% gelatin-collated coverslips. The following day,
the zebrafish myogenic cells attached were fixed in
4% paraformaldehyde (Electron Microscopy Scien-
ces) at 4C for 10 minutes. To block nonspecific
binding of the antibodies, slides were incubated for
30 minutes at room temperature in PBS þ 10% goat
serum. After blocking, the slides were incubated over-
night at 4C using the primary antibodies. Slides
were washed three times in 1 PBS, and sections
were incubated with Alexa 488 (anti-mouse IgG)- or
568 (anti-rabbit IgG)-conjugated goat secondary anti-
bodies (Invitrogen) at a 1:500 dilution for 45 minutes
at room temperature. The slides were then washed
three times in 1 PBS before mounting in Vecta-
shield with 40,6-diamidino-2-phenylindole (DAPI)
(Vector Laboratories). Slides were analyzed by micro-
scope (E1000 Nikon Eclipse; Nikon) and OpenLab
software.
RNA Isolation and Microarray Analysis. RNA was
extracted directly from zebrafish myogenic progen-
itor cells in culture at various stages of differentia-
tion using Tripure (Roche Applied Science), fol-
lowing the manufacturer’s protocol. Zebrafish
cDNA was hybridized to the Affymetrix GeneChip
Zebrafish Genome Array (GenBank Release 36.0,
June 2003) and processed following the manufac-
turer’s protocol at the Molecular Genetics Core
Facility at Children’s Hospital Boston. The result-
ing .CEL files, which contain probe signal inten-
sities of the samples, were preprocessed and nor-
malized together using robust multiarray averaging
(RMA), which returns the expression level of each
probe set or gene as a positive real number in log-
arithmic base 2 scale.20 The complete microarray
data are available from the NCBI Gene Expression
Omnibus (GEO) as GSE19754.
Principal component analysis (PCA) was used
to survey gene variation across sample (time) and
space, and sample variation across transcriptome
space, separately.21 Because most of the time-
points had replicate sample measurements, we
computed the linear correlation between the
unlogged replicate time profiles (A, B) for each
probe set to assess the reproducibility of their time
profile. We selected the probe set with the maxi-
mum replicate time profile correlation as the
unique representative for genes with more than
one probe set representative. The fold change of a
probe set for days 10–14 vs. days 0–1 was computed
as the average RMA signal of days 10–14 minus the
average RMA signal of days 0–1. This fold change
is in log base 2 scale, because the RMA signal is in
log base 2 scale. Gene ontology (GO) enrichment
analysis was performed using the Database for
Annotation, Visualization, and Integrated Discovery
(DAVID 6.7; http://david.abcc.ncifcrf.gov) on the
mouse homologs of zebrafish genes, because the
ontological characterization of genes is currently
richer for the mouse than for the zebrafish.22 We
used the mouse C2C12 myogenic differentiation
microarray dataset (GEO, GSE19968) for compara-
tive genomic analysis.23
Quantitative Real-TimePolymeraseChain Reaction. Total
RNA (1 lg) was extracted from the zebrafish mus-
cle myogenic progenitor cells in culture at various
time-points during differentiation and subjected to
reverse transcriptase using the First Strand Synthe-
sis Kit (Invitrogen). cDNA was then diluted in ster-
ile water into tenfold serial dilutions, and real-time
polymerase chain reaction (PCR) was performed
(SYBR Green Master Mix; Applied Biosystems).
Gene-specific primers that overlapped introns were
used (refer to Supplementary Material, Table S5).
All samples were amplified on a light cycler
(Model 7900HT; ABI). Cycle time (CT) values
were normalized to a zebrafish ef1a loading con-
trol. All significant values were determined using
Student t-tests (two-tailed).
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RESULTS
Isolation and Differentiation of Adult Zebrafish
Myogenic Progenitor Cells. In mammals, it is possi-
ble to identify muscle progenitor cells by their
potential to differentiate into multinucleate myo-
tubes in culture. To access this capability in adult
zebrafish, myogenic progenitor cells were prepared
from a-actin–RFP transgenic zebrafish, as outlined
in Figure 1 and detailed in the previous section.
Following cellular expansion, after reaching 95%þ
confluency (after being plated at 300,000 cells 24
hours earlier), the myogenic progenitor cells were
exposed to differentiation medium. Over the
course of 14 days, cultured zebrafish muscle cells
began to fuse and elongate (Fig. 2). The use of
the a-actin–RFP transgenic line allowed for the
easy identification of mature myotubes in contrast
to any few remaining fibroblasts due to the skeletal
muscle-specific enhancer that drives expression of
the RFP reporter, as characterized elsewhere.17
Initial plating of primary myoblasts from the a-
actin–RFP fish resulted in very few RFP-positive
cells either attached to the plates or free floating
in the medium (Fig. 2A–H). At day 4, several clus-
ters of RFP-positive cells emerged as the myoblasts
began to undergo cellular fusion. The detection of
RFP (a-actin) reporter was a strong indicator that
the zebrafish myogenic progenitors had begun to
activate transcripts essential for myoblast fusion
and myotube structure, as the a-actin gene (pro-
moter for RFP) expression is most robust in
mature myofibers.17,24 By day 7, long multi-
nucleated RFPþ myotubes were identified that fur-
ther expanded into twitching myotube clusters by
day 14 (Fig. 2H).
To further characterize what stage of myogenesis
these adult zebrafish myogenic progenitors resided
in at the initial time of isolation (day 0), the cells
were probed using immunofluoresence with the
myogenic determination markers pax3 and pax7.
Mammalian pax3 and pax7 function as determinants
of the transition from embryonic myoblasts into mus-
cle satellite cells, whereas, in zebrafish, these proteins
function in the determination of fast muscle fibers
used for swimming.11 Day 0 zebrafish myogenic pro-
genitor cells had low levels of pax3 (1.53%) and
pax7 (2.86%) protein expression, as quantified by
immunofluorescence with monoclonal specific anti-
bodies (Fig. 2I, J, and M). Conversely, these day 0
myogenic progenitors had significant levels of myod1
(74.86%), indicating that these cells were further
committed than mammalian satellite cells to form
myotubes (Fig. 2K and M). In addition, these cells
had low expression of myogenin (3.27%) (Fig. 2L
and M), a marker of myofiber determination. These
experiments demonstrate that isolated myogenic pro-
genitor cells can successfully fuse in cell culture as
visualized by the a-actin–RFP fluorescent reporter,
similar to the myoblast culture of larger fish species,
such as the Atlantic salmon.13
Transcriptome Profiles of Cell Fusion and
Differentiation of Zebrafish Myogenic
Progenitor Cells. To identify the myogenic tran-
scriptome of zebrafish myogenic progenitor cells
from cell proliferation through cell fusion and
FIGURE 1. Basic protocol for the isolation of zebrafish skeletal muscle myogenic progenitor cells from whole dorsal myotome. Sche-
matic showing the procedure for the isolation of skeletal myogenic progenitors from adult zebrafish dorsal muscle. Following euthaniza-
tion of the zebrafish with tricaine, the fish are skinned, decapitated, de-finned, and de-gutted. A disassociation step in a mixture of
collagenase IV and neutral protease breaks down cellular adhesion, whereas the use of a Ficoll gradient results in the isolation of a
mononuclear cell layer. Pre-plating on uncoated plates was followed by an overnight (16-hour) transfer of the myoblast-enriched super-
natant to gelatin-coated plates. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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differentiation into mature myotubes, total mRNA
was interrogated by microarray at different time-
points (days 0, 1, 4, 7, 10, and 14) from zebrafish
myogenic progenitor cells of the a-actin–RFP trans-
genic line as the cells underwent myogenic differ-
entiation in culture.
Duplicate biological measurements (A, B)
were made for most time-points. For each micro-
array gene probe set, we computed the correla-
tion between duplicate profiles to assess the
reproducibility of the myogenic developmental
profile of the gene. There were 5960 microarray
gene probe sets with a correlation >0.8 between
duplicate profiles. Unless otherwise noted, this is
the primary microarray gene set used in subse-
quent analyses. PCA of the standardized tempo-
ral expression profiles of these genes show them
to have two large-scale temporal patterns (Fig.
3). Fifty-six percent (3340 genes, 2985 unique)
have a profile that largely decreases with time
(green dots, left hemisphere of PCA plot in Fig.
3A) and are enriched for development and cell
signaling receptor ontologic terms (Supplemental
Material, Table S1). Forty-four percent (2620
genes, 2414 unique) have a profile that is
largely increasing with time (magenta dots, right
hemisphere of PCA plot in Fig. 3A) and are
enriched for oxidoreductive and metabolic
enzyme ontologic terms (Supplementary Material,
Table S2). The majority of genes change their
expression level at day 4: high to low, and vice
versa (Fig. 3B). Phenotypically, zebrafish muscle
cells at day 4 of myogenic differentiation are in
the initial stages of myotube fusion. To identify
the active genes at day 4, we performed a differ-
ential analysis of day 4 vs. the other days (0, 1,
7, 10, and 14). Forty-seven unique genes were
significantly upregulated at day 4 relative to the
FIGURE 2. In vitro differentiation of primary myoblasts isolated from a-actin–RFP adult dorsal muscle. (A–D) Phase contrast of zebra-
fish myogenic progenitor cells differentiating from day 0 to day 14. (E–H) RFP expression of the a-actin promoter indicates myotube
formation and myogenic differentiation. (I–L) Immunofluorescent staining of day 0 a-actin-–RFP myoblasts. Note that very few cells
express high levels of the a-actin RFP transgene, as it undergoes higher levels of transcriptional expression during myogenic differen-
tiation. Green fluorescent staining and open arrowheads demarcate myogenic markers (pax3, pax7, myod1, and myogenin). (M) Quan-
tification of 500 DAPI-stained (blue) nuclei of the results from day 0 myoblast immunofluorescent staining in (I)–(L). Immunostaining
was performed in triplicate. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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other days and were enriched for M-phase and
mitosis ontologic terms (Supplementary Material,
Table S3). Sixty unique genes were significantly
downregulated at day 4 relative to the other days
and were enriched for collagen and extracellular
matrix ontological terms (Supplementary Material,
Table S4). In addition, we examined the microar-
ray expression profile of nine reproducible tran-
scripts that have been reported previously to be
differentially expressed during myogenesis.25
Zebrafish Myogenic Progenitor Cells Express
Myogenic Genes at Critical Time-Points during Differ-
entiation. After myogenic progenitor cell microar-
ray analysis of the zebrafish, samples were validated
by quantitative real-time PCR for several important
myogenic genes using exon-overlapping primers.
Several myogenic structural (acta1a, desma), cell-sig-
naling (cav3, cxcr4a), and transcription (myog,
pax3a) factors were chosen for validation. In each
case, each gene followed the expected microarray
FIGURE 3. Microarray analysis of zebrafish myogenic progenitor cell differentiation transcriptome. (A) Principal components analysis
(PCA) showing the principal components 1 vs. 2 plot of the zebrafish muscle cell differentiation microarray data of 5960 reproducible
genes (shown as colored dots) in time and indicates two large-scale temporal patterns of expression. Genes on the left hemisphere
(green) are highly expressed at days 0–1, and decrease over time. Genes on the right hemisphere (magenta) show low expression at
days 0–1, and increase over time. The principal components axes are a linear combination of the time-points. (B) The average expres-
sion profile of the genes from the two large-scale temporal patterns of expression. (C) Standardized expression for upregulation (red)
vs. downregulation (green) of nine differentially regulated myogenic genes. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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FIGURE 4. Validation of myogenic differentiation in the zebrafish myogenic progenitor cells by microarray and real-time PCR. (A)
Real-time quantitative PCR expression (magenta dashed line) levels of six myogenic differentiation factors (acta1a, cav3, cxcr4a,
desma, myog, and pax3a) across time (x-axis; days 0–14) as compared with microarray data (green solid line). The y-axis is logarithm
base 2 scale fold change of each time-point relative to day 0, which is the average DCT (day 0) minus average DCT (day N) value for
quantitative PCR data (ddCT), and average RMA signal (day N) minus average RMA signal (day 0) for the microarray data. The quan-
titative PCR CT values were normalized to the zebrafish housekeeping gene ef1a housekeeping per condition. Note that acta1 and
cxcr4 primers were specific to both a and b isoforms present in the zebrafish genome. (B) The table compares the log2 expression
fold change of days 0–1 vs. 10–14 of the six myogenic differentiation factors between quantitative PCR and microarray data. [Color fig-
ure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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trend across myogenic differentiation (Fig. 4). The
myogenic structural genes (acta1a and desma) were
all upregulated as the zebrafish myogenic progeni-
tor cells underwent myogenic fusion and myotube
formation. As expected, the myogenic stem cell
marker (cxcr4a) mRNA was downregulated as the
zebrafish muscle cells underwent fusion, whereas,
conversely, the myogenic transcription factor myo-
genin (myog) was upregulated. In addition, another
marker of early myoblasts, pax3a, had significantly
reduced expression as the cells underwent myo-
genic differentiation.
Comparison of Zebrafish Myogenic Progenitor Cell
Transcriptome with other Mammalian Myogenic Tran-
scriptomes: Strengths and Limitations. To gain
insights into similarities between zebrafish and
mammalian myogenic cells with respect to changes
in gene expression during in vitro differentiation,
we compared the zebrafish myogenic differentiation
transcriptome data to a recent mouse C2C12 myo-
genic differentiation microarray dataset from the
GEO, GSE19968.23 PCA of samples in transcriptome
space of both datasets, done separately, showed a
distinct dichotomy between the earlier vs. later
time-points of myogenic differentiation along the
first principal component (PC1), the direction of
maximum sample variation (Fig. 5A). There is a
clear transcriptome scale distinction when compar-
ing days 0–1 vs. days 7–10 in the zebrafish, and
between myoblasts and differentiated myotubes at
day 4 in C2C12. There are 3784 homologous genes
in common between the datasets, and 1400 have a
correlation of >0.8 between replicate time profiles
in both datasets, respectively. Of these 1400 repro-
ducible genes, we investigated the concordance of
differential expression of earlier vs. later time-points
during myogenic differentiation. We computed the
fold change of days 10–14 relative to days 0–1 in
the zebrafish, and of myotubes at day 4 relative to
myoblasts in C2C12. There was significant concord-
ance among genes that were twofold magnitude
changed at earlier vs. later time-points in both data-
sets: Fisher exact test P-value <7.0  107 (Fig. 5B).
DISCUSSION
Gene expression profiles of early differentiating
zebrafish myogenic progenitor cells show expres-
sion profiles similar to those expected for mamma-
lian muscle, namely that the expression of many
sarcomeric proteins is strongly upregulated with
differentiation. In comparison with microarray
data from mouse C2C12 myoblast differentiation,25
many of the same myogenic differentiation factors,
such as Pax3, Myf5, and MyoD1, decrease in tran-
script. Although Pax3 is a determinant of embry-
onic mouse myoblasts, recent studies involving the
use of Pax3–green fluorescent protein (GFP)
knock-in mice have revealed that a very small pop-
ulation of Pax3-positive myogenic progenitors does
persist in adult muscle and are capable of restoring
skeletal muscle after injury.26 In zebrafish dorsal
muscle, a pax3- and pax7-positive myogenic progen-
itor population is essential for the expansion of
fast- and slow-twitch myofibers through an
upstream regulation of myf5 and myod1.27 It is
likely that a similar population of pax3- and/or
pax7-positive myogenic progenitors exists in adult
zebrafish skeletal muscle, and will contribute to
myofiber formation following injury. In addition,
the presence and subsequent downregulation of a
cxcr4a (a homolog of mammalian Cxcr4) cell pop-
ulation during myogenic differentiation is consist-
ent with its role as a myogenic progenitor marker
that can be used in myoblast transplantation.28 A
transparent zebrafish strain that completely lacks
pigmentation, the casper line, allows for the trans-
plantation and long-term monitoring of fluores-
cently labeled cell populations into adult fish. One
can envision that, after the isolation of adult zebra-
fish myogenic progenitor cells from skeletal muscle
transgenic fish lines, engraftment of different pop-
ulations could be observed in vivo, allowing for the
capture in real time of the behavior of trans-
planted cells. This information is essential for the
optimization of cell transplantation approaches
(now available with the development of this zebra-
fish myogenic progenitor isolation protocol) which
cannot be visualized in mice at the level of resolu-
tion that can be achieved in zebrafish.
In mice, many procedures have been used to
purify muscle progenitor cells, although, in all
cases, the purified population is still heterogene-
ous, requiring additional pre-plating purification
to enrich for cells with myogenic potential.16 We
have modified the mammalian pre-plating tech-
nique, added a Ficoll-gradient procedure to
decrease bacterial contamination, and demon-
strated that myogenic cells can be isolated and dif-
ferentiated in cell culture. These results show that
zebrafish have adult muscle progenitor cells that
can be isolated and differentiated in cell culture.
In conclusion, we have isolated a myogenic pro-
genitor cell in zebrafish dorsal muscle. We have
shown that gene expression profiles in these zebra-
fish myogenic progenitor cells are similar to those
of mammals. This successful culture and differen-
tiation of a myogenic progenitor population
expands the utility of the zebrafish in the study of
adult skeletal muscle mutants. High-throughput
screening of chemical libraries has allowed
researchers to correct mutations in zebrafish
mutants and holds promise for the treatment of
muscular dystrophy and myopathies.29 Given the
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FIGURE 5. Comparison of zebrafish and mouse C2C12 myogenic development. (A) Principal components analysis of samples in tran-
scriptome space showing principal components 1 vs. 2, and 1 vs. 3 plots for the zebrafish and C2C12 (from Gene Expression Omni-
bus, GSE19968) data show transcriptome scale distinctions between earlier vs. later time-points of muscle development: days 0–1 vs.
days 7–10 in zebrafish, and myoblasts vs. differentiated myotubes at day 4 in C2C12. Zebrafish samples are labeled by the time-point
following myogenic differentiation (days 0–14). C2C12 samples are labeled as myoblasts (B), and time-points following myogenic
differentiation (days 0, 1, and 4). (B) Contingency table of genes 2-fold magnitude changed in earlier vs. later time-points of 1400
reproducible genes common to both datasets: fold change of days 10–14 relative to days 0–1 in zebrafish, and fold change of myo-
tubes at day 4 relative to myoblasts in C2C12. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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gaps in the zebrafish genome annotation that have
frustrated researchers,30 it is likely that the release of
a well-annotated copy of the zebrafish genome will
lead to improved microarray platforms and increased
use of the zebrafish in large-scale transcriptome stud-
ies. Until then, rigorous validation of zebrafish tran-
scriptome data by quantitative reverse transcription
PCR is essential for drawing valid conclusions from
zebrafish microarray transcriptome experiments. Fur-
ther studies using zebrafish myogenic progenitor
cells to identify novel drug compounds will show
them to be an attractive, cost-effective alternative to
large-scale mammalian studies.
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